Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 422

Results For "EU"

5432 News Found

Venus Remedies gets CII's Responsible Export Organisation Certification
News | April 13, 2022

Venus Remedies gets CII's Responsible Export Organisation Certification

A comprehensive assessment of the organisational systems for governance, management, operations and consistency in delivered results, this certification is an endorsement of the company's export capabilities and manufacturing prowess


Switzerland grants conditional marketing authorisation for Novavax Covid-19 vaccine
Biotech | April 13, 2022

Switzerland grants conditional marketing authorisation for Novavax Covid-19 vaccine

Nuvaxovid is the first protein-based Covid-19 vaccine authorized for use in Switzerland


Wacker, CordenPharma to produce mRNA vaccines for Germany
News | April 12, 2022

Wacker, CordenPharma to produce mRNA vaccines for Germany

Both companies have been selected for stand-by production by German government


Jorge Gomez joins Moderna as Chief Financial Officer
People | April 12, 2022

Jorge Gomez joins Moderna as Chief Financial Officer

Gomez joins Moderna from Dentsply Sirona, where he served as Executive Vice President & Chief Financial Officer since August 2019


Carestream installs DRX Compass at Gati Diagnostic Centre
Medical Device | April 12, 2022

Carestream installs DRX Compass at Gati Diagnostic Centre

The DRX-Compass helps navigate and accelerate towards superb performance with a solution that grows with its customers


PhableCare raises Rs 187 crore in Series B funding
Startup | April 12, 2022

PhableCare raises Rs 187 crore in Series B funding

The funding round is led by Kalaari Capital. Aflac Ventures, Digital Horizon, Stride Ventures, and existing investors also participated in the round


Aleor receives USFDA approval for Lidocaine and Prilocaine Cream
Drug Approval | April 12, 2022

Aleor receives USFDA approval for Lidocaine and Prilocaine Cream

Lidocaine and Prilocaine Cream USP, 2.5%/2.5% has an estimated market size of US $ 29 million for twelve months ending Dec. 2021 according to IQVIA


ReiThera and Exothera collaborate to develop large-scale, low cost per dose vaccine
Biotech | April 12, 2022

ReiThera and Exothera collaborate to develop large-scale, low cost per dose vaccine

Collaboration awarded €3 million grant by the Bill & Melinda Gates Foundation


Cambrex completes large-scale US API expansion
Biotech | April 12, 2022

Cambrex completes large-scale US API expansion

The expansion positions Cambrex with the largest and most advanced API facility in the United States


Global pharma back Turn Biotechnologies to advance its cell rejuvenation program
Startup | April 11, 2022

Global pharma back Turn Biotechnologies to advance its cell rejuvenation program

Daewoong Pharmaceutical, HanAll Biopharma join Astellas Venture Management and other VCs in oversubscribed funding round to accelerate Turn Bio's preclinical advances in multiple therapeutic areas